Etropal AD (XBUL:ETR) Research & Development : лв0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Etropal AD Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Etropal AD's Research & Development for the three months ended in Dec. 2023 was лв0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was лв0.00 Mil.

Etropal AD Research & Development Historical Data

The historical data trend for Etropal AD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD Research & Development Chart

Etropal AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

Etropal AD Quarterly Data
	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Dec23
Research & Development	Get a 7-Day Free Trial														-	-	-	-	-

Etropal AD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.00 Mil.

Etropal AD (XBUL:ETR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Etropal AD Research & Development Related Terms

Thank you for viewing the detailed overview of Etropal AD's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Etropal AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Rusky Boulevard, Etropole, Sofia, BGR, 2180

Website

http://www.etropal.eu

Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.